The Company is revising its previously given guidance relating to full year 2025 net revenue and Adjusted EBITDA due to the following factors: (1) the German Federal Institute for Drugs and Medical ...
Non-GAAP financial measure. Refer to "Cautionary Statement Regarding Certain Non-GAAP Measures" for further details. Click to enlarge 2025 Updated Guidance The Company is revising its previously given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results